Press-release for stocks

Prices are updated after-hours

| 71.87% | O: -1.53% H: 2.34% C: -1.82%
bb-301 biopharma phase 1 positive trial phase 1b phase 2b

Benitec Biopharma Provides Positive Updates on the BB-301 Pilot Dosing Study in Large Animals
Published: 2021-09-08 (Crawled : 12:00) - ir.benitec.com
BNTC | $6.99 4.02% 3.86% 26K

| 71.87% | O: -1.53% H: 2.34% C: -1.82%
bb-301 biopharma animals positive

78%

22%

MTTR | News 4 | $4.6 164.37% 62.17% 28M

AGBA | $2.94 135.2% 57.48% 66M

EDBL | News | $6.46 71.81% 41.8% 2M

MTC | $2.25 44.23% 30.67% 6M

OPRT | News | $3.175 41.11% 29.13% 12M

SHIM | $3.05 35.56% 26.23% 1.1M

HKIT | $1.345 31.86% 24.16% 390K

ABVC | $1.36 30.77% 23.53% 7.4M

OST | $0.512 28.0% 21.88% 290K

POET | $1.59 27.2% 21.38% 4.2M

Save your searches and get alerts when important news are released.